Genetic health technology and economic evaluation: a critical review.

abstract：BACKGROUND:Early awareness and alert systems have been established in many countries but evidence on their ability to accurately prioritize new medicines (for early assessment) is limited. OBJECTIVE:The purpose of this study was to assess whether the Swedish Early Awareness and Alert System identified and prioritized ...

journal_title：Applied health economics and health policy

authors： Eriksson I,von Euler M,Malmström RE,Godman B,Wettermark B

更新日期：2019-02-01 00:00:00

abstract：:In Germany, the Institute for Quality and Efficiency in Health Care (IQWiG) makes recommendations for ceiling prices of drugs based on an evaluation of the relationship between costs and effectiveness. To set ceiling prices, IQWiG uses the following decision rule: the incremental cost-effectiveness ratio (ICER) of a n...

journal_title：Applied health economics and health policy

authors： Gandjour A

更新日期：2011-03-01 00:00:00

abstract：:The Peristeen transanal irrigation system is intended to allow people with bowel dysfunction to flush out the lower part of the bowel as part of their bowel management strategy. Peristeen was the subject of an evaluation by the National Institute for Health and Care Excellence, through its Medical Technologies Evaluat...

journal_title：Applied health economics and health policy

authors： Dale M,Morgan H,Carter K,White J,Carolan-Rees G

更新日期：2019-02-01 00:00:00

abstract：:The first objective of this paper is to expound the particular challenge posed by the occurrence of inconsistency in the expression of preferences by mental health patients to both economists and policy makers. Since this difficulty cannot be resolved, the second aim of the paper is to identify agents who may be count...

journal_title：Applied health economics and health policy

authors： Zweifel P

更新日期：2020-04-01 00:00:00

abstract：BACKGROUND:This research seeks to identify the relationship between economic factors related to the ability to receive and pay for health services and adverse cancer outcomes, as well as preventative screening and behavioral factors that influence the risk of cancer. We focus on the Northern High Plains region, where w...

journal_title：Applied health economics and health policy

authors： Belasco EJ,Gong G,Pence B,Wilkes E

更新日期：2014-08-01 00:00:00

abstract：BACKGROUND:The clinical management of intracranial aneurysms is debated in many countries because of the associated disability risk and costs. Therefore, estimating the costs and explaining their variability will provide important information for decision makers. OBJECTIVE:We aimed to evaluate the acute and post-acute...

journal_title：Applied health economics and health policy

authors： Calciolari S,Torbica A,Tarricone R

更新日期：2013-08-01 00:00:00

abstract：:This paper examines the use of propensity score matching in economic analyses of observational data. Several excellent papers have previously reviewed practical aspects of propensity score estimation and other aspects of the propensity score literature. The purpose of this paper is to compare the conceptual foundation...

journal_title：Applied health economics and health policy

authors： Crown WH

更新日期：2014-02-01 00:00:00

abstract：:Health state utility values are a major source of uncertainty in economic evaluations of interventions for age-related macular degeneration (AMD). This review identifies and critiques published utility values and methods for eliciting de novo utility values in AMD. We describe how utility values have been used in heal...

journal_title：Applied health economics and health policy

authors： Butt T,Tufail A,Rubin G

更新日期：2017-02-01 00:00:00

abstract：BACKGROUND:The management of the large patient population in Italy receiving long-term oral anticoagulation therapy (OAT) poses organizational challenges that are traditionally approached with a centralized procedure, relying on hospital-based clinics and/or GPs. However, the availability of near-patient testing device...

journal_title：Applied health economics and health policy

authors： Pradelli L,Iannazzo S,Zaniolo O,Botrugno P

更新日期：2010-01-01 00:00:00

abstract：BACKGROUND:Response to growth hormone (GH) therapy may vary between individual patients. Therefore the use of GH in children should be closely monitored to avoid over, under, or ineffective treatment regimens. The treatment response can be evaluated using growth prediction models. In an effort to improve the accuracy o...

journal_title：Applied health economics and health policy

authors： Kaspers S,Ranke MB,Han D,Loftus J,Wollmann H,Lindberg A,Roelants M,Kleintjens J

更新日期：2013-06-01 00:00:00

abstract：BACKGROUND:Treatment with antipsychotic medication is an important element of relapse prevention in the management of schizophrenia, and can reduce inpatient stays. Recently, the long-acting atypical antipsychotic paliperidone long-acting injectable (PLAI), a once-monthly LAI antipsychotic, was approved for treatment o...

journal_title：Applied health economics and health policy

authors： Zeidler J,Mahlich J,Greiner W,Heres S

更新日期：2013-10-01 00:00:00

abstract：:The debate surrounding whether the findings of efficacy studies are applicable to real-world treatment situations is ongoing. The issue of lack of applicability due to a lack of clinical heterogeneity could be addressed by employing less restrictive inclusion criteria. Given that health economic assessments based on c...

journal_title：Applied health economics and health policy

authors： Richter A,Thieda P,Thaler K,Gartlehner G

更新日期：2011-05-01 00:00:00

abstract：BACKGROUND:Canadian patients, healthcare providers and payers share interest in assessing the value of self-monitoring of blood glucose (SMBG) for individuals with type 2 diabetes but not on insulin. Using the UKPDS (UK Prospective Diabetes Study) model, the Canadian Optimal Prescribing and Utilization Service (COMPUS)...

journal_title：Applied health economics and health policy

authors： Tunis SL

更新日期：2011-11-01 00:00:00

abstract：BACKGROUND:Decision makers within the Calgary Health Region adopted and applied programme budgeting and marginal analysis (PBMA) for priority-setting activity across major service portfolios within the Region. METHODS:Seventeen in-depth qualitative interviews were conducted with senior managers and clinicians to gain ...

journal_title：Applied health economics and health policy

authors： Mitton C,Patten S,Donaldson C

更新日期：2004-01-01 00:00:00

abstract：BACKGROUND:Liposomal amphotericin B (L-AMB) and amphotericin B lipid complex (ABLC) are both indicated for treating invasive fungal infections (IFIs) caused by Aspergillus, Candida and Cryptococcus spp. among patients who are refractory to or intolerant of conventional amphotericin B (CAB). Prior studies have suggested...

journal_title：Applied health economics and health policy

authors： Yang H,Chaudhari P,Zhou ZY,Wu EQ,Patel C,Horn DL

更新日期：2014-02-01 00:00:00

abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is the second most common cancer in Taiwan. For males in Taiwan, it is the most dangerous cancer, with both the highest incidence and mortality rate. OBJECTIVE:To determine cancer-related medical care costs for long-term survivors of HCC. METHODS:The estimation of the lifetim...

journal_title：Applied health economics and health policy

authors： Lang HC,Wu JC,Yen SH,Lan CF,Wu SL

更新日期：2008-01-01 00:00:00

abstract：BACKGROUND:Low back pain (LBP) is a major health problem, having a substantial effect on peoples' quality of life and placing a significant economic burden on healthcare systems and, more broadly, societies. Many interventions to alleviate LBP are available but their cost effectiveness is unclear. OBJECTIVES:To identi...

journal_title：Applied health economics and health policy

authors： Andronis L,Kinghorn P,Qiao S,Whitehurst DG,Durrell S,McLeod H

更新日期：2017-04-01 00:00:00

abstract：:Memokath-051 is a thermo-expandable, nickel-titanium alloy spiral stent used to treat ureteric obstruction resulting from malignant or benign strictures. The National Institute for Health and Care Excellence (NICE) selected Memokath-051 for evaluation. The company, PNN Medical, claimed Memokath-051 has clinical superi...

journal_title：Applied health economics and health policy

authors： Eaton Turner E,Jenks M,McCool R,Marshall C,Millar L,Wood H,Peel A,Craig J,Sims AJ

更新日期：2018-08-01 00:00:00

abstract：BACKGROUND:In Slovenia during the period 2000-2010, the number of years of potential life lost before the age of 70 years per 100,000 population under 70 years of age declined 25 %. OBJECTIVE:The aim of this study was to test the hypothesis that pharmaceutical innovation played a key role in reducing premature mortali...

journal_title：Applied health economics and health policy

authors： Lichtenberg FR

更新日期：2015-04-01 00:00:00

abstract：:Central line-associated bloodstream infections (CLABSIs) are primary, laboratory confirmed bloodstream infections in patients with a central line within 48 h of symptom onset. Catheter-related bloodstream infection (CRBSI) is a more specific term used when the cause of infection has been confirmed by catheter tip cult...

journal_title：Applied health economics and health policy

authors： O'Connell S,Dale M,Morgan H,Carter K,Carolan-Rees G

更新日期：2020-08-05 00:00:00

abstract：BACKGROUND:Although the costs of treating inflammatory bowel disease (IBD) in developed countries are well established, they remain largely unknown in countries with recent histories of socio-economic transition including Serbia. OBJECTIVE:To estimate the costs of treatment including the resources used by patients wit...

journal_title：Applied health economics and health policy

authors： Kostić M,Djakovic L,Šujić R,Godman B,Janković SM

更新日期：2017-02-01 00:00:00

abstract：OBJECTIVES:Invasive pneumococcal disease (IPD), pneumonia and acute otitis media (AOM) still represent a significant medical burden in children < 5 years of age in New Zealand (NZ), with marked disparities across socio-economic and ethnic groups. This cost-effectiveness evaluation aims to compare the potential impact o...

journal_title：Applied health economics and health policy

authors： Varghese L,Talbot L,Govender A,Zhang XH,Mungall BA

更新日期：2018-06-01 00:00:00

abstract：BACKGROUND:Immunization rates for human papillomavirus (HPV) infections remain low among teenagers despite strong evidence of the effectiveness of vaccines. Physician recommendations of the vaccine are far from universal. Several states have enacted policies that mandate HPV vaccination or distribute educational materi...

journal_title：Applied health economics and health policy

authors： Moghtaderi A,Adams S

更新日期：2016-06-01 00:00:00

abstract：:We conducted a scoping review with the objective of synthesizing available literature and mapping what designs and methods have been used to evaluate health insurance reforms in sub-Saharan Africa. We systematically searched for scientific and grey literature in English and French published between 1980 and 2017 using...

journal_title：Applied health economics and health policy

authors： Degroote S,Ridde V,De Allegri M

更新日期：2020-12-01 00:00:00

abstract：BACKGROUND:Employers are increasingly relying on rewards programmes in an effort to promote greater levels of activity among employees; however, if enrolment in these programmes is dominated by active employees, then they are unlikely to be a good use of resources. OBJECTIVE:This study uses a stated-preference survey ...

journal_title：Applied health economics and health policy

authors： Ozdemir S,Bilger M,Finkelstein EA

更新日期：2017-10-01 00:00:00

abstract：OBJECTIVES:The objective of this study was to construct an early economic evaluation for acalabrutinib for relapsed chronic lymphocytic leukaemia (CLL) to assist early reimbursement decision making. Scenarios were assessed to find the relative impact of critical parameters on incremental costs and quality-adjusted life...

journal_title：Applied health economics and health policy

authors： Vreman RA,Geenen JW,Hövels AM,Goettsch WG,Leufkens HGM,Al MJ

更新日期：2019-12-01 00:00:00

abstract：BACKGROUND:little is known about the economics of acquiring and processing the more than 14 million units of red blood cells used annually in the US. OBJECTIVE:to determine the average price paid by hospitals to suppliers for a unit of red blood cells and to identify cost variations by region and facility type and siz...

journal_title：Applied health economics and health policy

authors： Toner RW,Pizzi L,Leas B,Ballas SK,Quigley A,Goldfarb NI

更新日期：2011-01-01 00:00:00

abstract：BACKGROUND:Cost-effectiveness analyses (CEAs) have been performed for oral non-disease-altering osteoarthritis (OA) treatments for well over a decade. During that period the methods for performing these analyses have evolved as pharmacoeconomic methods have advanced, new treatments have been introduced, and the knowled...

journal_title：Applied health economics and health policy

authors： Wielage RC,Myers JA,Klein RW,Happich M

更新日期：2013-12-01 00:00:00

abstract：BACKGROUND:As tuberculosis screening trends to targeting high-risk populations, knowing the cost effectiveness of such screening is vital to decision makers. OBJECTIVES:The purpose of this review was to compile cost-utility analyses evaluating latent tuberculosis infection (LTBI) screening in high-risk populations tha...

journal_title：Applied health economics and health policy

authors： Campbell JR,Sasitharan T,Marra F

更新日期：2015-08-01 00:00:00

abstract：BACKGROUND:When pharmaceuticals are administered based on patient characteristics (for example weight or body surface area), an amount of product will be unused and must be disposed of. This wastage represents inefficiency and can distort decision making. METHODS:We present a method for the analysis of optimum fill vo...

journal_title：Applied health economics and health policy

authors： Hatswell AJ,Porter JK

更新日期：2019-06-01 00:00:00